Literature DB >> 12499378

Functional analysis of TBX5 missense mutations associated with Holt-Oram syndrome.

Chun Fan1, Mugen Liu, Qing Wang.   

Abstract

TBX5 is a T-box transcription factor that plays a critical role in organogenesis. Seven missense mutations in TBX5 have been identified in patients with Holt-Oram syndrome characterized by congenital heart defects and upper limb abnormalities. However, the functional significance and molecular pathogenic mechanisms of these mutations are not clear. In this study we describe functional defects in DNA binding, transcriptional activity, protein-protein interaction, and cellular localization of mutant TBX5 with these missense mutations (Q49K, I54T, G80R, G169R, R237Q, R237W, and S252I). Mutations G80R, R237Q, and R237W represent a group of mutations that dramatically reduce DNA-binding activity of TBX5, leading to reduced transcription activation by TBX5 and the loss of synergy in transcriptional activation between TBX5 and NKX2.5. The second group of mutations includes Q49K, I54T, G169R, and S252I, which have no or moderate effect on DNA-binding activity and the function of transcription activation of TBX5 but cause the complete loss of synergistic transcription activity between TBX5 and NKX2.5. All seven missense mutations greatly reduced the interaction of TBX5 with NKX2.5 in vivo and in vitro. Immunofluorescent staining showed that wild type TBX5 was localized completely into the nucleus, but mutants were localized in both nucleus and cytoplasm. These results demonstrate that all seven missense mutations studied here are functional mutations with a spectrum of defects ranging from decreases in DNA-binding activity and transcriptional activation to the dramatic reduction of interaction between TBX5 and NKX2.5, and loss of synergy in transcriptional activation between these two proteins, as well as impairment in the nuclear localization of TBX5. These defects are likely central to the pathogenesis of Holt-Oram syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12499378      PMCID: PMC1579789          DOI: 10.1074/jbc.M208120200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Combinatorial expression of GATA4, Nkx2-5, and serum response factor directs early cardiac gene activity.

Authors:  Jorge L Sepulveda; Spiros Vlahopoulos; Dinakar Iyer; Narasimhaswamy Belaguli; Robert J Schwartz
Journal:  J Biol Chem       Date:  2002-04-30       Impact factor: 5.157

2.  Familial heart disease with skeletal malformations.

Authors:  M HOLT; S ORAM
Journal:  Br Heart J       Date:  1960-04

3.  Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome.

Authors:  M Bamshad; R C Lin; D J Law; W C Watkins; P A Krakowiak; M E Moore; P Franceschini; R Lala; L B Holmes; T C Gebuhr; B G Bruneau; A Schinzel; J G Seidman; C E Seidman; L B Jorde
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

4.  Crystallographic structure of the T domain-DNA complex of the Brachyury transcription factor.

Authors:  C W Müller; B G Herrmann
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

5.  The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and ankyloglossia.

Authors:  C Braybrook; K Doudney; A C Marçano; A Arnason; A Bjornsson; M A Patton; P J Goodfellow; G E Moore; P Stanier
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

6.  A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease.

Authors:  B G Bruneau; G Nemer; J P Schmitt; F Charron; L Robitaille; S Caron; D A Conner; M Gessler; M Nemer; C E Seidman; J G Seidman
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

7.  Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family.

Authors:  Q Y Li; R A Newbury-Ecob; J A Terrett; D I Wilson; A R Curtis; C H Yi; T Gebuhr; P J Bullen; S C Robson; T Strachan; D Bonnet; S Lyonnet; I D Young; J A Raeburn; A J Buckler; D J Law; J D Brook
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

8.  Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome.

Authors:  C T Basson; D R Bachinsky; R C Lin; T Levi; J A Elkins; J Soults; D Grayzel; E Kroumpouzou; T A Traill; J Leblanc-Straceski; B Renault; R Kucherlapati; J G Seidman; C E Seidman
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

9.  Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome.

Authors:  B G Bruneau; M Logan; N Davis; T Levi; C J Tabin; J G Seidman; C E Seidman
Journal:  Dev Biol       Date:  1999-07-01       Impact factor: 3.582

10.  Holt-Oram syndrome: a clinical genetic study.

Authors:  R A Newbury-Ecob; R Leanage; J A Raeburn; I D Young
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

View more
  40 in total

1.  A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome.

Authors:  Masao Murakami; Masayo Nakagawa; Eric N Olson; Osamu Nakagawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-06       Impact factor: 11.205

2.  Jmjd3 and UTX play a demethylase-independent role in chromatin remodeling to regulate T-box family member-dependent gene expression.

Authors:  Sara A Miller; Sarah E Mohn; Amy S Weinmann
Journal:  Mol Cell       Date:  2010-11-24       Impact factor: 17.970

Review 3.  Common themes emerge in the transcriptional control of T helper and developmental cell fate decisions regulated by the T-box, GATA and ROR families.

Authors:  Sara A Miller; Amy S Weinmann
Journal:  Immunology       Date:  2009-03       Impact factor: 7.397

4.  Functional role of transcriptional factor TBX5 in pre-mRNA splicing and Holt-Oram syndrome via association with SC35.

Authors:  Chun Fan; Qiuyun Chen; Qing Kenneth Wang
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

5.  Cloning and characterization of the human SH3BP2 promoter.

Authors:  Chun Fan; Robert J Gaivin; Thomas A Marth; Belinda Willard; Michael A Levine; Steven A Lietman
Journal:  Biochem Biophys Res Commun       Date:  2012-07-17       Impact factor: 3.575

6.  Novel TBX5 duplication in a Japanese family with Holt-Oram syndrome.

Authors:  Masato Kimura; Atsuo Kikuchi; Natsuko Ichinoi; Shigeo Kure
Journal:  Pediatr Cardiol       Date:  2014-10-02       Impact factor: 1.655

7.  Novel exons in the tbx5 gene locus generate protein isoforms with distinct expression domains and function.

Authors:  Abir Yamak; Romain O Georges; Massomeh Sheikh-Hassani; Martin Morin; Hiba Komati; Mona Nemer
Journal:  J Biol Chem       Date:  2015-01-25       Impact factor: 5.157

8.  Hox5 interacts with Plzf to restrict Shh expression in the developing forelimb.

Authors:  Ben Xu; Steven M Hrycaj; Daniel C McIntyre; Nicholas C Baker; Jun K Takeuchi; Lucie Jeannotte; Zachary B Gaber; Bennett G Novitch; Deneen M Wellik
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 9.  T-box factors determine cardiac design.

Authors:  W M H Hoogaars; P Barnett; A F M Moorman; V M Christoffels
Journal:  Cell Mol Life Sci       Date:  2007-03       Impact factor: 9.261

10.  Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype.

Authors:  Anna-Marie E Brassington; Sandy S Sung; Reha M Toydemir; Trung Le; Amy D Roeder; Ann E Rutherford; Frank G Whitby; Lynn B Jorde; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2003-06-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.